US Stock MarketDetailed Quotes

ARDS Aridis Pharmaceuticals

Watchlist
  • 0.000
  • 0.0000.00%
15min DelayClose Mar 11 16:00 ET
4.46KMarket Cap0.00P/E (TTM)

About Aridis Pharmaceuticals Company

Aridis Pharmaceuticals, Inc. engages in the discovery and development of targeted immunotherapy using human monoclonal antibodies, or mAbs, to treat infections. The company was founded by Eric J. Patzer and Vu L. Truong on April 24, 2003 and is headquartered in Los Gatos, CA.

Company Profile

SymbolARDS
Company NameAridis Pharmaceuticals
Listing DateAug 14, 2018
Issue Price13.00
Founded2014
CEODr. Vu Truong, PhD
MarketPink Market
Employees37
Fiscal Year Ends12-31
Address983 University Avenue,Building B
CityLos Gatos
ProvinceCalifornia
CountryUnited States of America
Zip Code95032
Phone1-408-385-1742

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Vu Truong, PhD
  • Director, Chief Executive Officer and Chief Scientific Officer
  • --
  • Fred Kurland
  • Chief Financial Officer and Principal Accounting Officer
  • --
  • Dr. Hasan Jafri
  • Chief Medical Officer
  • --
  • Dr. Eric Patzer, PhD
  • Executive Chairman of the Board
  • --
  • John F. Hamilton
  • Independent Director
  • --
  • Dr. Susan Richards Windham-Bannister, PhD
  • Independent Director
  • --
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.